Order Article Reprints

Manzar GS, De BS, Abana CO, Lee SS, Javle M, Kaseb AO, Vauthey J-N, Tran Cao HS, Koong AC, Smith GL, et al. Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers. 2022; 14(8):1901. https://doi.org/10.3390/cancers14081901

Manzar, Gohar Shahwar, Brian Sandeep De, Chike Osita Abana, Sunyoung S. Lee, Milind Javle, Ahmed O. Kaseb, Jean-Nicolas Vauthey, Hop Sanderson Tran Cao, Albert C. Koong, Grace Li Smith, and et al. 2022. "Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma" Cancers 14, no. 8: 1901. https://doi.org/10.3390/cancers14081901

Manzar, G. S., De, B. S., Abana, C. O., Lee, S. S., Javle, M., Kaseb, A. O., Vauthey, J.-N., Tran Cao, H. S., Koong, A. C., Smith, G. L., Taniguchi, C. M., Holliday, E. B., Das, P., Koay, E. J., & Ludmir, E. B. (2022). Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers, 14(8), 1901. https://doi.org/10.3390/cancers14081901